| (1S,2R)-2-Phenylcyclopropan-1-amine;(1R,2S)-2-phenylcyclopropan-1-amine | IC50 | 5950.0 [1] |
| Voriconazole | IC50 | 5250.0 [1], 8700.0 [2], 15000.0 [3] |
| Voriconazole | Ki | 5100.0 [1] |
| alpha-Naphthoflavone | IC50 | 10000.0 [1], 20000.0 [2] |
| Ketoconazole | IC50 | 10100.0 [1], 19000.0 [2] |
| Modafinil | IC50 | 11000.0 [1] |
| (S)-(+)-N-3-Benzylnirvanol | IC50 | 138.0 [1], 211.0 [2], 294.0 [3] |
| 4-[4-[2-[(3S)-3-Hydroxy-1-azabicyclo[2.2.2]octan-3-yl]ethynyl]phenoxy]-N-(pyrimidin-4-ylmethyl)benzamide | IC50 | 7943.28 [1], 10000.0 [2], 50118.72 [3] |
| Verapamil | IC50 | 21800.0 [1], 30000.0 [2] |
| Haloperidol | IC50 | 2870.0 [1], 50000.0 [2] |
| Ticlopidine | IC50 | 1300.0 [1], 28400.0 [2] |
| Fluconazole | IC50 | 8200.0 [1] |
| Sertraline | IC50 | 310.0 [1], 22500.0 [2] |
| Duloxetine | IC50 | 4100.0 [1] |
| Miconazole | IC50 | 17900.0 [1], 18000.0 [2] |
| Nicardipine | IC50 | 560.0 [1], 3300.0 [2] |
| Pentamidine | IC50 | 100000.0 [1] |
| Parnate | IC50 | 3040.0 [1], 5000.0 [2] |
| Tranylcypromine | IC50 | 3100.0 [1], 5000.0 [2] |
| 4-[(7-Chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol;hydrochloride | IC50 | 85000.0 [1] |
| Bepridil | IC50 | 100.0 [1], 32200.0 [2] |
| Gingerol | IC50 | 10900.0 [1], 30700.0 [2] |
| Dolutegravir | IC50 | 100000.0 [1] |
| Benzbromarone | IC50 | 18200.0 [1] |
| Benzbromarone | Ki | 3700.0 [1] |
| Saxagliptin | IC50 | 50000.0 [1] |
| (10)-Gingerol | IC50 | 6600.0 [1], 13600.0 [2] |
| Pleconaril | IC50 | 10000.0 [1], 50118.72 [2] |
| Desethylamodiaquine | IC50 | 54000.0 [1] |
| S1RA | IC50 | 10000.0 [1] |
| Bms-536924 | IC50 | 2000.0 [1] |
| Paradol | IC50 | 3600.0 [1], 17600.0 [2] |
| Temsavir | IC50 | 25000.0 [1], 40000.0 [2] |
| (8)-Gingerol | IC50 | 8100.0 [1], 12500.0 [2] |
| 3-(5-(4-(1H-Imidazol-1-yl)phenyl)-1-(4-carbamoyl-2-methylphenyl)-1H-pyrrol-2-yl)propanoic acid | IC50 | 770.0 [1] |
| 4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine | IC50 | 10000.0 [1], 50000.0 [2] |
| (1S,3S,5S)-2-[(2S)-2-Amino-2-(3,5-dihydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile | IC50 | 200000.0 [1] |
| Isoquine | IC50 | 39000.0 [1] |
| 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide | IC50 | 100000.0 [1] |
| 2,3-Dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo[1,2-a]pyridine-6-carboxamide | IC50 | 20000.0 [1] |
| (3R)-N-Isoquinolin-3-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine | IC50 | 40000.0 [1] |
| TGR5 Receptor Agonist | IC50 | 316.23 [1] |
| 2-(2-(4-Tert-Butylphenylthio)ethyl)-1H-imidazole | IC50 | 8.5 [1] |
| CID 46244454 | IC50 | 10000.0 [1] |
| 1-Cyclohexyl-2-(furan-3-yl)-N-[(1S)-2-(5-hydroxy-1H-indol-3-yl)-1-(1,3-thiazol-4-yl)ethyl]benzimidazole-5-carboxamide | IC50 | 2400.0 [1] |
| 3-(1-Naphthyl)-1-(4-pyridinyl)-2-propen-1-one | IC50 | 10000.0 [1], 20000.0 [2] |
| (E)-3-(2-Chlorophenyl)-1-(1H-pyrrol-2-yl)prop-2-en-1-one | IC50 | 10000.0 [1], 20000.0 [2] |
| 1-Cyano-3-(2-methyl-1-benzofuran-5-yl)-2-[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]guanidine | IC50 | 40000.0 [1], 200000.0 [2] |
| Bms-344577 | IC50 | 51000.0 [1], 200000.0 [2] |
| 2-(4-Fluorophenyl)-N-[6-methoxy-5-(4-methylimidazol-1-yl)pyridin-2-yl]-1-methylbenzimidazol-4-amine | IC50 | 3500.0 [1] |
| 2-((Pyridin-2-ylmethyl)thio)-1H-benzo[d]imidazole | IC50 | 50000.0 [1] |
| 2-((Pyridin-2-ylmethyl)thio)-1H-benzo[d]imidazole | Ki | 50.0 [1] |
| N-[4-[(1R,2R)-2-(Dimethylamino)-1-imidazol-1-ylpropyl]phenyl]-1,3-benzothiazol-2-amine | IC50 | 350.0 [1], 5900.0 [2] |
| Linaprazan | IC50 | 100000.0 [1] |
| (5-Pyrid-3-ylthien-2-YL)methylamine | IC50 | 2000.0 [1] |
| (5-Pyrid-3-ylthien-2-YL)methylamine | Ki | 1000.0 [1] |
| (5-(Pyridin-3-YL)furan-2-YL)methanamine | IC50 | 22000.0 [1] |
| (5-(Pyridin-3-YL)furan-2-YL)methanamine | Ki | 11000.0 [1] |
| 3-[(E)-[3-[(E)-2-[4-[(Dimethylamino)methyl]phenyl]ethenyl]indazol-6-ylidene]methyl]-1H-indol-2-ol | IC50 | 1000.0 [1] |
| [3-[4-[[(3S,5R)-3,5-Dimethylpiperazin-1-yl]methyl]phenyl]pyridin-2-yl]-[4-(4-fluoroanilino)piperidin-1-yl]methanone | IC50 | 23000.0 [1], 100000.0 [2] |
| N-(2,4-Dichlorobenzyl)-4-(pyrimidin-2-yloxy)piperidine-1-carboxamide | IC50 | 19000.0 [1] |
| MCH-1 antagonist 1 | IC50 | 10000.0 [1] |
| 3-(1H-Imidazol-4-yl)pyridine | IC50 | 53500.0 [1] |
| 3-(1H-Imidazol-4-yl)pyridine | Ki | 26800.0 [1] |
| Methyl 3-imidazol-1-yl-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propanoate | IC50 | 100.0 [1], 1500.0 [2] |
| (E)-3-[4-[[1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-ylindole-6-carbonyl)amino]cyclobutanecarbonyl]amino]phenyl]prop-2-enoic acid | IC50 | 2900.0 [1] |
| 6-Chloro-7-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-2-(1,3-dimethylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine | IC50 | 30.0 [1], 10000.0 [2] |
| 1-(4-Butoxy-phenyl)-1H-imidazole | IC50 | 7.0 [1] |
| Pyridine, 3-(1-methyl-1H-imidazol-4-yl)- | IC50 | 122100.0 [1] |
| Pyridine, 3-(1-methyl-1H-imidazol-4-yl)- | Ki | 61000.0 [1] |
| 3-(4-Methylthiophen-3-yl)pyridine | IC50 | 24900.0 [1] |
| 3-(4-Methylthiophen-3-yl)pyridine | Ki | 12500.0 [1] |
| (2R)-2-(2,4-Difluorophenyl)-2-[(2R,5R)-5-(2,3-dihydro-1H-inden-2-yl)-2-(2-methylpropyl)-3,6-dioxopiperazin-1-yl]-N,N-dimethylacetamide | IC50 | 38000.0 [1], 100000.0 [2] |
| 2-((4'-Chlorobiphenyl-2-yl)methylsulfinyl)acetamide | IC50 | 19000.0 [1], 112000.0 [2] |
| 2-(Ethylsulfanyl)-6-methoxy-1h-benzimidazole | IC50 | 50000.0 [1] |
| 2-(Ethylsulfanyl)-6-methoxy-1h-benzimidazole | Ki | 42500.0 [1] |
| 3-[(E)-[3-[(E)-2-Pyridin-4-ylethenyl]indazol-6-ylidene]methyl]-1H-indol-2-ol | IC50 | 130.0 [1] |
| 5-Methoxy-3-[(E)-[3-[(E)-2-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]ethenyl]indazol-6-ylidene]methyl]-1H-indol-2-ol | IC50 | 800.0 [1], 1600.0 [2] |
| 3-(2-Methyl-1H-imidazol-1-yl)pyridine | IC50 | 300000.0 [1] |
| 3-(2-Methyl-1H-imidazol-1-yl)pyridine | Ki | 300000.0 [1] |
| 3-(3-Methylthiophen-2-yl)pyridine | IC50 | 20100.0 [1] |
| 3-(3-Methylthiophen-2-yl)pyridine | Ki | 10100.0 [1] |
| 4-(1-(2,4-Dichlorobenzylcarbamoyl)piperidin-4-yloxy)benzoic acid | IC50 | 30000.0 [1] |
| 1-[(2-Chloroquinolin-3-yl)methyl]-6-fluoro-5-methyl-3-(2-oxo-1H-pyridin-3-yl)indole-2-carboxylic acid | IC50 | 50000.0 [1] |
| 6-Methyl-2-(pyridin-2-ylmethylsulfanyl)-1H-benzimidazole | IC50 | 50.0 [1] |
| 6-Methyl-2-(pyridin-2-ylmethylsulfanyl)-1H-benzimidazole | Ki | 20.0 [1] |
| 2-(3,5-Dimethoxybenzylthio)-6-methoxy-1H-benzo[d]imidazole | IC50 | 50000.0 [1] |
| 2-(3,5-Dimethoxybenzylthio)-6-methoxy-1H-benzo[d]imidazole | Ki | 70.0 [1] |
| 6-Methoxy-2-(naphthalen-2-ylmethylthio)-1H-benzo[d]imidazole | IC50 | 50000.0 [1] |
| 6-Methoxy-2-(naphthalen-2-ylmethylthio)-1H-benzo[d]imidazole | Ki | 60.0 [1] |
| 1-[4-[3-[(2R)-2-Methylpyrrolidin-1-yl]propoxy]phenyl]-2-morpholin-4-ylethanone | IC50 | 30000.0 [1] |
| 7-[(cis-4-Aminocyclohexyl)amino]-5-Bromo-1-Benzofuran-2-Carboxylic Acid | IC50 | 10000.0 [1] |
| [(8R)-3-[2-(2,4-Difluorophenyl)-1,3-thiazol-4-yl]-8-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-(4-thiophen-2-ylphenyl)methanone | IC50 | 4000.0 [1] |
| CID 56593147 | IC50 | 20000.0 [1] |
| (2'S,3R)-5-Methoxy-2'-[3-[(E)-2-[4-(morpholin-4-ylmethyl)phenyl]ethenyl]-1H-indazol-6-yl]spiro[1H-indole-3,1'-cyclopropane]-2-one | IC50 | 1200.0 [1], 2100.0 [2] |
| (2'S,3R)-2'-[3-[(E)-2-[4-(Morpholin-4-ylmethyl)phenyl]ethenyl]-1H-indazol-6-yl]spiro[1H-indole-3,1'-cyclopropane]-2-one | IC50 | 800.0 [1], 1800.0 [2] |
| (2'S,3R)-2'-[3-[(E)-2-[4-[(Dimethylamino)methyl]phenyl]ethenyl]-1H-indazol-6-yl]spiro[1H-indole-3,1'-cyclopropane]-2-one | IC50 | 1000.0 [1] |
| (2'S,3R)-5-Methoxy-2'-[3-[(E)-2-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]ethenyl]-1H-indazol-6-yl]spiro[1H-indole-3,1'-cyclopropane]-2-one | IC50 | 1500.0 [1], 1600.0 [2] |
| (2'S,3R)-2'-[3-[(E)-2-[4-[(Dimethylamino)methyl]phenyl]ethenyl]-1H-indazol-6-yl]-5-methoxyspiro[1H-indole-3,1'-cyclopropane]-2-one | IC50 | 750.0 [1], 2000.0 [2] |
| 3-(3-Thienyl)pyridine | IC50 | 111200.0 [1] |